Course Listings: Oncology

All Results (19)
Format: Live Events (0) Online Activities (19)

Beyond the Horizon: The Promise of Novel Therapies for Relapsed/Refractory DLBCL

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This accredited CME publication explores emerging treatment strategies for diffuse large B-cell lymphoma (DLBCL), including their mechanisms of action, efficacy data, and safety data; it also discusses novel therapies in clinical development for relapsed/refractory DLBCL. Additionally, expert faculty offer their perspectives on the integration of emerging…More


Recent Advances in the Management of Gaucher Disease Type 3

View Course

Format: Presentation Points

Maximum Credits: 0.5

Course Description: This transcript-based, CME-accredited Presentation Points publication highlights key points from a satellite symposium presented by nationally renowned experts on Gaucher disease type 3 (GD3) Pramod K. Mistry, MD, PhD, FRCP, and Raphael Schiffmann, MD, MHSc, FAAN. Faculty review the diagnostic potential of various investigational GD3 biomarkers and provide…More


ROS1 in the Driver’s Seat: Emerging Science and Evolving Strategies in the Treatment of ROS1-Positive NSCLC

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This publication reviews ROS1 gene fusions as an oncogenic driver of non–small cell lung cancer (NSCLC) and available methods for detecting these rearrangements in patients with advanced NSCLC. Data surrounding emerging tyrosine kinase inhibitors (TKIs) that are effective against ROS1-positive NSCLC are also explored. Additionally, audio clips of faculty are…More


Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the First-Line Treatment of Metastatic Urothelial Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive, case-based activity discusses PD-L1 testing in patients newly diagnosed with metastatic urothelial cancer and focuses on immunotherapeutic treatment options for patients with PD-L1–positive tumors. Links to useful resources are provided to help participants make treatment decisions for the patient, and an expert faculty member offers his…More


Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive, case-based activity discusses the integration of immune checkpoint inhibitors into treatment strategies for patients with refractory/recurrent advanced or metastatic UC. Links to useful resources are provided to help participants make treatment decisions for the patient, and an expert faculty member offers his perspective on the latest…More


Combatting Treatment-Naïve, Extensive-Stage SCLC With Novel Immunotherapeutic Strategies

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This accredited publication highlights current evidence regarding the use of immune checkpoint inhibitors (ICIs) in combination with standard chemotherapy for patients with treatment-naïve, extensive-stage small cell lung cancer (ES-SCLC). It also examines the implications of incorporating ICIs into first-line ES-SCLC therapy on clinical management and…More


Understanding the Role of Patient-Reported Outcomes in Oncology

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This publication explores how patient-reported outcomes (PROs) can be used to better understand the effects that cancer and cancer treatments have on health outcomes and the overall patient experience. Practical tips and best practices to implementing PROs in a clinic’s workflow are discussed.


Incorporating the Latest Therapeutic Advances and Shared Decision Making Into Clinical Practice

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses the treatment of patients with advanced classical Hodgkin lymphoma (cHL), with a focus on novel therapeutic strategies both in first-line and refractory/relapsed settings. In addition, brief clinical case vignettes are included to illustrate how disease-, treatment-, and patient-related factors affect management decisions.


Optimizing Patient-Centered cHL Care: Prompt Recognition and Management of Adverse Events and Empowering Patients

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses best practices in the management of treatment toxicities in patients with advanced classical Hodgkin lymphoma (cHL), along with strategies to educate and support patients throughout the continuum of care. Brief clinical case vignettes are included to illustrate strategies for monitoring for and managing adverse events.


Decision-IQ: A Case Study in Managing Biochemical Recurrence of Prostate Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this short case-based activity, meet Ed, a 59-year-old man who experiences a biochemical recurrence of prostate cancer. As you move through this activity, read through links to useful resources to help you make clinical management decisions for this patient. In addition, find out how Judd Moul, MD, would manage Ed’s recurrence to help reduce his risk of…More


Advances in Breast Cancer

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: This 30-minute webcast reviews recent updates and current clinical evidence in breast cancer management, including the latest surgical techniques, the use of genomic medicine in HR+/HER2- early stage breast cancer, and radiotherapy fractionation for early stage breast cancer.


Advances in the Management of Brain Metastases

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty review recent advances in the management of brain malignancies. In particular, April K.S. Salama, MD, discusses the current understanding of systemic therapy, John Kirkpatrick, MD, PhD, discusses advances in radiation therapy, and Peter Fecci, MD, PhD, discusses surgical improvements for brain metastasis.


Advances in the Treatment of Renal Cell Carcinoma

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty discuss recent advances in the treatment of renal cell carcinoma.


Recent Advances in the Treatment of Hematologic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty explore recent advances in the treatment of hematologic malignancies. In particular, CAR T-cell therapy for relapsed and refractory diffuse large B-cell lymphoma and FLT3-targeted treatment in AML are discussed.


Recent Therapeutic Advances for Thoracic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty highlight recent clinical evidence on the care of patients with thoracic malignancies. The role of surgery and radiotherapy in treating patients with small cell and non–small cell lung cancer in the era of immunotherapy is discussed, as well as the current standard of care for patients with advanced metastatic non–small…More


GFR and eGFR: Filtering Out the Confusion

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: Nephrologist Dr. Michael Wiederkehr delves into chronic kidney disease (CKD) and the difference between true glomerular filtration rate (GFR) and estimated glomerular filtration rate (eGFR). The different methods of calculating eGFR will be explored as well as the pitfalls and limitations of the current formulas and calculations. The importance of the CKD…More


Decision-IQ: Assessing Risk and Preventing Tumor Lysis Syndrome

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This brief case-based, digital CME activity incorporates current evidence-based prophylaxis algorithms to assess the risk of tumor lysis syndrome (TLS) in a patient with chronic lymphocytic leukemia (CLL) undergoing anticancer therapy. Links to relevant literature and expert insights are provided to help clinicians prevent and manage TLS.


Decision-IQ: Prostate Cancer Screening in the Geriatric Population

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive case-based activity discusses the risks and benefits of prostate cancer screening in the geriatric population. Links to useful resources are provided to help participants make treatment decisions for the patient, and expert faculty offer their perspectives on the latest evidence for these management decisions.


Raising the Bar in NHL Through the Provision of Shared Decision Making

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This 30-minute, interactive digital publication interweaves clinical patient cases as well as patient, caregiver, and clinician insights from national surveys to examine the role of shared decision making in non-Hodgkin lymphoma. Evidence-based guideline recommendations for managing patients with follicular lymphoma and diffuse large B-cell lymphoma, as well as…More